Adalimumab Market In Latin America
i am a market research analyst currently researching on humira/adalimumab market scenario in latin america. I am specifically analysing the market by indications and country. Rheumatoid arthritis, psoriasis, crohn's disease, ulcerative colitis and others. Request you to kindly refer me to the concerned person well versed with this market with immediate effect.
Awaiting positive response
mugdha+13 Other Responses
Need an industry expert on immunology market. He/she should have extensive knowledge on one of these market segments such as:
glucocorticoids, non-biologic disease modifying drugs and biologics;
ankylosing spondylitis, crohn’s disease, multiple sclerosis, psoriasis, rheumatoid arthritis, systemic lupus erythematosus, ulcerative colitis;
tumor necrosis factor- alpha, interleukin-6 and receptor, interleukin – 1,2,5,12,17 & 23 and receptors)
(humira (adalimumab), remicade (infliximab), enbrel (etanercept), rituxan (rituximab), stelara (ustekinumab), progra (tacrolimus), cimzia (certolizumab pegol), simponi (golimumab), entyvio (vedolizumab).
The expert should be able to provide insights on the following for the above: market size, company shares, market trends, and price trends. As well as knowledge regarding country-wide usage for us and europe regarding the price trends and market shares will be helpful.
+12 Other Responses
Development of rapid tests for autoimmune diseases
nature of activity requested〈project description〉:
identify autoimmune disease test for chinese population
evaluation of clinical sample design and collection.
Sample management and data management,
screen antibody/antigen for the tests.
Selection of 5 assays for assay development
patient sample collection.
Data analysis and modeling
finish clinical sample design and experimental design.
Select comprehensive targeting auto antibodies for chinese population
collect patient samples and store properly.
Develop reliable assays.
Finish data analysis and establish 5 tests.+14 Other Responses